Clinical Trials Browser

OTHER × Neurotoxicity Syndromes × Duloxetine Hydrochloride × Clear all

NCT06551051 2024-09-19

ADC-induced Neurotoxicity Treated With Duloxetine

Phase 2 Recruiting

Neurotoxicity Syndromes

NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase 3 Completed

231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes